Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 105Neoplasm Metastasis 6Neoplasms 4Breast Diseases 4Ovarian Neoplasms 3Neoplasms by Site 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Triple Negative Breast Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Anatomic Stage II Breast Cancer AJCC v8 2Advanced Breast Cancer 2Venous Thromboembolism 1Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Osteitis Deformans 1Neoplastic Cells, Circulating 1Mesothelioma 1Lymphoma 1Lung Neoplasms 1Locoregional Recurrence 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Leukemia 1Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1Hematologic Neoplasms 1

Interventions

entinostat 2ribociclib 1pembrolizumab 1palbociclib 1olaparib 1alectinib 1Tinzaparin 1Sorafenib 1Paclitaxel 1Genetic Testing 1Genetic Counseling 1Fulvestrant 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × ribociclib × Breast × Clear all
NCT05238922 2026-04-14

Study of INCB123667 in Subjects With Advanced Solid Tumors

Incyte Corporation

Phase 1 Recruiting
604 enrolled
BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡